bone-seeking antibiotic prodrugs (Targanta)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namebone-seeking antibiotic prodrugs (Targanta)
Drug Alias Namebisphosphonate-linked fluoroquinolones (Targanta)rifabutin-bisphosphonaterifabutin-linked fluoroquinolones (Targanta)TT-99000647
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsOsteomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTarganta Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarganta Therapeutics
Active IndicationsN/A
Inactive IndicationsOsteomyelitis

Other Information

ATC CodeN/A
Related LinksN/A